• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

渗透型释放口崩型哌甲酯治疗注意缺陷多动障碍青少年学习技能的效果:一项开放性研究。

Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study.

机构信息

Department of Psychiatry, College of Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea.

出版信息

Int Clin Psychopharmacol. 2013 Jul;28(4):184-92. doi: 10.1097/YIC.0b013e3283612509.

DOI:10.1097/YIC.0b013e3283612509
PMID:23587983
Abstract

We evaluated the effect of osmotic-release oral system (OROS) methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder (ADHD). In an open-label study, 121 adolescents with ADHD were administered flexible doses of OROS methylphenidate for 12 weeks. The efficacy of methylphenidate on ADHD symptoms was evaluated by ADHD Rating Scale (ARS) and Clinical Global Impression Scale (CGI). Learning Skills Test (LST) was used to measure the learning skills of the participants at the baseline and the endpoint. Continuous performance test, visuospatial and verbal working memory, verbal fluency, and inhibition were evaluated before and after the 12 weeks of treatment. The mean total and subscores of LST were significantly increased after the 12-week treatment with OROS methylphenidate. Executive functions were also improved during the trial, with the exception of inhibition measured by the Stroop Test. To the best of our knowledge, this is the first study to examine the influence of OROS methylphenidate on learning skill. As a result, OROS methylphenidate was effective in enhancing learning skills in adolescents with ADHD.

摘要

我们评估了渗透型控释片(OROS)哌甲酯对注意缺陷多动障碍(ADHD)青少年学习技能的影响。在一项开放性研究中,121 名 ADHD 青少年接受了为期 12 周的 OROS 哌甲酯的灵活剂量治疗。ADHD 症状的疗效通过 ADHD 评定量表(ARS)和临床总体印象量表(CGI)进行评估。学习技能测试(LST)用于测量参与者在基线和终点的学习技能。在治疗前和治疗 12 周后评估连续性能测试、视空间和言语工作记忆、言语流畅性和抑制。经过 12 周 OROS 哌甲酯治疗后,LST 的总分和子评分显著提高。在试验过程中,执行功能也得到了改善,除了通过斯特鲁普测试测量的抑制。据我们所知,这是第一项研究 OROS 哌甲酯对学习技能的影响。结果表明,OROS 哌甲酯可有效提高 ADHD 青少年的学习技能。

相似文献

1
Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study.渗透型释放口崩型哌甲酯治疗注意缺陷多动障碍青少年学习技能的效果:一项开放性研究。
Int Clin Psychopharmacol. 2013 Jul;28(4):184-92. doi: 10.1097/YIC.0b013e3283612509.
2
Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.去甲肾上腺素转运蛋白-3081(A/T) 和α-2A-肾上腺素能受体 MspI 多态性与 OROS-哌甲酯治疗的心血管副作用有关。
J Psychopharmacol. 2012 Mar;26(3):380-9. doi: 10.1177/0269881111405356. Epub 2011 May 31.
3
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.盐酸哌甲酯控释片治疗青少年注意力缺陷/多动障碍的多中心对照研究。
Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90. doi: 10.1001/archpedi.160.1.82.
4
OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.奥罗莫苯丙胺对 ADHD 成人特定执行功能缺陷的疗效:一项随机、安慰剂对照交叉研究。
Eur Neuropsychopharmacol. 2014 Apr;24(4):519-28. doi: 10.1016/j.euroneuro.2014.01.007. Epub 2014 Jan 18.
5
Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.托莫西汀和渗透泵控释型哌甲酯对注意缺陷多动障碍(混合型)患者执行功能的影响
J Child Adolesc Psychopharmacol. 2015 Aug;25(6):494-500. doi: 10.1089/cap.2014.0155. Epub 2015 Jul 28.
6
Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial.奥昔布宁控释片与托莫西汀治疗 ADHD 患者执行功能的对照研究:一项随机对照试验。
Int J Neuropsychopharmacol. 2012 Feb;15(1):15-26. doi: 10.1017/S1461145711001490. Epub 2011 Oct 21.
7
Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder.一项针对中国学龄期注意缺陷多动障碍儿童的开放性标签奥洛他定治疗的前瞻性自然研究。
Chin Med J (Engl). 2011 Oct;124(20):3269-74.
8
Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.控释型哌甲酯能否改善核心症状及执行功能缺陷?针对成人注意力缺陷多动障碍的开放标签试验结果
Curr Med Res Opin. 2006 Dec;22(12):2557-66. doi: 10.1185/030079906X154132.
9
A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities.一项试点研究:盐酸哌甲酯控释片对合并或不合并行为共病的注意力缺陷多动障碍儿童工作记忆和注意力功能的不同影响。
Atten Defic Hyperact Disord. 2011 Mar;3(1):13-20. doi: 10.1007/s12402-010-0035-x. Epub 2010 Oct 21.
10
Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.在 ADHD 儿童/青少年中,从缓释哌甲酯转换为渗透控释哌甲酯的效果:一项 3 个月非干预性研究的结果。
Curr Med Res Opin. 2011;27 Suppl 2:35-44. doi: 10.1185/03007995.2011.601733. Epub 2011 Jul 25.

引用本文的文献

1
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.注意缺陷多动障碍儿童和青少年使用哌甲酯后出现的幻觉及其他精神病性症状:一项Cochrane系统评价,包括荟萃分析和试验序贯分析
Scand J Child Adolesc Psychiatr Psychol. 2018 Jul 10;6(1):52-71. doi: 10.21307/sjcapp-2018-003. eCollection 2018.
2
Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder: A Meta-analysis.评估哌醋甲酯在注意缺陷多动障碍中的安全性和最大剂量滴定原理:一项荟萃分析。
JAMA Pediatr. 2019 Jul 1;173(7):630-639. doi: 10.1001/jamapediatrics.2019.0905.
3
Assessing Executive Function in Adolescence: A Scoping Review of Existing Measures and Their Psychometric Robustness.评估青少年的执行功能:对现有测量方法及其心理测量稳健性的范围综述。
Front Psychol. 2019 Mar 1;10:311. doi: 10.3389/fpsyg.2019.00311. eCollection 2019.
4
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
5
A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.奥昔哌汀(专注达(®))治疗注意缺陷多动障碍的研究综述。
CNS Drugs. 2014 Nov;28(11):1005-33. doi: 10.1007/s40263-014-0175-1.